{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:03:53Z","timestamp":1751353433798,"version":"3.40.5"},"reference-count":26,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Pharm Policy and Pract"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and to its publication. With an interest in pharmaceutical care and in clinical pharmacy, Dr. van Mil changed practice and policy in Europe over the last decades in\u00a0a very visible way, here documented through a summary of some of his main written contributions. We write this to honour his memory and contribute to the preservation of his legacy.<\/jats:p>","DOI":"10.1186\/s40545-020-00253-z","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T06:02:53Z","timestamp":1597989773000},"source":"Crossref","is-referenced-by-count":1,"title":["Impact of a global leader on pharmaceutical practice and policy around the world"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-2514","authenticated-orcid":false,"given":"F.","family":"Alves da Costa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-7691","authenticated-orcid":false,"given":"M.","family":"Henman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-6021","authenticated-orcid":false,"given":"C.","family":"Hughes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7175-1499","authenticated-orcid":false,"given":"H.","family":"Leufkens","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-3240","authenticated-orcid":false,"given":"Z.","family":"Babar","sequence":"additional","affiliation":[]},{"given":"J.","family":"McElnay","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-7322","authenticated-orcid":false,"given":"M.","family":"Schulz","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"253_CR1","first-page":"567","volume":"32","author":"RL Mikael","year":"1975","unstructured":"Mikael RL, Brown TR, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Hosp Pharm. 1975;32:567\u201374.","journal-title":"Am J Hosp Pharm"},{"key":"253_CR2","volume-title":"Pharmaceutical care, the future of pharmacy: theory, research, and practice [thesis]","author":"JWF van Mil","year":"2000","unstructured":"van Mil JWF. Pharmaceutical care, the future of pharmacy: theory, research, and practice [thesis]. The Netherlands: University of Groningen; 2000."},{"key":"253_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00735966","volume":"18","author":"JWF van Mil","year":"1996","unstructured":"van Mil JWF, Tromp TFJ. Pharmaceutical care in the Netherlands. History, definition and projects. Pharm World Sci. 1996;18:237\u201340.","journal-title":"Pharm World Sci"},{"issue":"4","key":"253_CR4","first-page":"539","volume":"41","author":"H Herborg","year":"2001","unstructured":"Herborg H, S\u00f8ndergaard B, Fr\u00f8kj\u00e6r B, Fonnesb\u00e6k L, J\u00f6rgensen T, Hepler CD, Grainger-Rousseau T-J, Ersb\u00f8ll BK. Improving drug therapy for patients with asthma \u2013 Part 1: Patient outcomes. J Am Pharm Assoc. 2001;41(4):539\u201350.","journal-title":"J Am Pharm Assoc"},{"key":"253_CR5","doi-asserted-by":"crossref","unstructured":"Schulz, M., Verheyen, F., M\u00fchlig, S., M\u00fcller, J.M., M\u00fchlbauer, K., Knop-Schneickert, E., Petermann, F. and Bergmann, K.-C. Pharmaceutical care services for asthma patients. A controlled intervention study. J Clin Pharmacol. 41, 2001, Vol. 6, pp. 668-676.","DOI":"10.1177\/00912700122010438"},{"issue":"1","key":"253_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/00002512-200118010-00005","volume":"18","author":"C Bernsten","year":"2001","unstructured":"Bernsten C, Bj\u00f6rkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, Gustafsson T, Henman M, Herborg H, Hughes CM, McElnay JC, Magner M, Van Mil F, Schaeffer M, Silva S, Sondergaard B, Sturgess I, Tromp D, Vivero L. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18(1):63\u201377.","journal-title":"Drugs Aging"},{"key":"253_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11096-004-2849-0","volume":"26","author":"JWF van Mil","year":"2004","unstructured":"van Mil JWF, Schulz M, Tromp TFJ. (Dick). Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review. Pharm World Sci. 2004;26:303\u201311.","journal-title":"Pharm World Sci"},{"issue":"1","key":"253_CR8","first-page":"155","volume":"7","author":"JWF van Mil","year":"2006","unstructured":"van Mil JWF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harvard Health Policy Review. 2006;7(1):155\u201368.","journal-title":"Harvard Health Policy Review"},{"issue":"146","key":"253_CR9","first-page":"1308","volume":"16","author":"F van Mil","year":"2001","unstructured":"van Mil F, Schaefer M, Verheyen F, Schulz M. Arzneimittelbezogene Probleme in der \u00f6ffentlichen Apotheke. Pharm Ztg. 2001;16(146):1308\u201314.","journal-title":"Pharm Ztg"},{"issue":"3","key":"253_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11096-005-7060-4","volume":"27","author":"BD Franklin","year":"2005","unstructured":"Franklin BD, van Mil JW. Defining clinical pharmacy and pharmaceutical care. Pharm World Sci. 2005;27(3):137.","journal-title":"Pharm World Sci"},{"issue":"1","key":"253_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11096-012-9728-x","volume":"35","author":"JW van Mil","year":"2013","unstructured":"van Mil JW, Fernandez-Llimos F. What is \u2018pharmaceutical care\u2019 in 2013? Int J Clin Pharm. 2013;35(1):1\u20132.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"253_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544\u201355.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"253_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","volume":"40","author":"N Griese-Mammen","year":"2018","unstructured":"Griese-Mammen N, Hersberger KE, Messerli M, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199\u2013208.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"253_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1345\/aph.1D182","volume":"38","author":"JW van Mil","year":"2004","unstructured":"van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859\u201367.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"253_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11096-010-9377-x","volume":"32","author":"PM Eichenberger","year":"2010","unstructured":"Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32(3):362\u201372.","journal-title":"Pharm World Sci"},{"key":"253_CR16","first-page":"2","volume":"38","author":"JF van Mil","year":"2016","unstructured":"van Mil JF, Westerlund T, Brown L, Chen TF, Henman M, Hersberger K, McElnay J, Schulz M. Medical care and drug-related problems: do doctors and pharmacists speak the same language? Int J Clin Pharm. 2016;38:2.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"253_CR17","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1345\/aph.1G141","volume":"39","author":"JW van Mil","year":"2005","unstructured":"van Mil JW. Pharmaceutical Care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother. 2005;39(10):1720\u20135.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"253_CR18","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1345\/aph.1K117","volume":"41","author":"A Alvarez-Risco","year":"2007","unstructured":"Alvarez-Risco A, van Mil JW. Pharmaceutical care in community pharmacies: practice and research in Peru. Ann Pharmacother. 2007;41(12):2032\u20137.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"253_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s11096-015-0140-1","volume":"37","author":"SF Martins","year":"2015","unstructured":"Martins SF, van Mil JW, da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharm. 2015;37(5):896\u2013905.","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"253_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.sapharm.2019.11.002","volume":"16","author":"TL Imfeld-Isenegger","year":"2020","unstructured":"Imfeld-Isenegger TL, Soares IB, Makovec UN, Horvat N, Kos M, van Mil F, et al. Community pharmacist-led medication review procedures across Europe: characterization, implementation and remuneration. Res Soc Adm Pharm. 2020;16(8):1057\u201366.","journal-title":"Res Soc Adm Pharm"},{"issue":"7099","key":"253_CR21","first-page":"854","volume":"264","author":"P Mason","year":"2000","unstructured":"Mason P. Pharmaceutical care: doing it the Dutch way. Pharm J. 2000;264(7099):854\u20135.","journal-title":"Pharm J"},{"key":"253_CR22","volume-title":"Introduction to Pharmaceutical Carefor the elderly","author":"JWF Van Mil","year":"1994","unstructured":"Van Mil JWF, Hepler CD. Drug therapy in the elderly: problems and solutions II: depression and hypertension. In: Hepler CD, editor. Introduction to Pharmaceutical Carefor the elderly. Lisbon: FIP; 1994."},{"key":"253_CR23","doi-asserted-by":"crossref","unstructured":"van Mil J W F, Frokjaer B, Tromp Th F J. Changing a profession, influencing community pharmacy. Pharm World Sci. 26, 2004, Vol. 3, pp. 129-132.","DOI":"10.1023\/B:PHAR.0000026821.51632.3b"},{"key":"253_CR24","unstructured":"Van Mil, F., & Tromp, D. Opieka farmaceutyczna: Jak wprowadzic j\u0105 w \u017cycie? armacja Polska. 57, 2001, Vol. 23, pp. 1063-1067."},{"key":"253_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11096-009-9286-z","volume":"31","author":"Z Babar","year":"2009","unstructured":"Babar Z, Beswick T. Southern Med Review: a new forum to publish \u201cLocal Pharmaceutical Policy in a Global Context\u201d. Pharm World Sci. 2009;31:143\u20134.","journal-title":"Pharm World Sci"},{"key":"253_CR26","doi-asserted-by":"crossref","unstructured":"Alves da Costa, F., van Mil, J., Alvarez Risco, A. The pharmacist guide to implementing pharmaceutical care. Springer, 2019.","DOI":"10.1007\/978-3-319-92576-9"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40545-020-00253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40545-020-00253-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40545-020-00253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:57:37Z","timestamp":1704279457000},"score":1,"resource":{"primary":{"URL":"https:\/\/joppp.biomedcentral.com\/articles\/10.1186\/s40545-020-00253-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1186\/s40545-020-00253-z","relation":{},"ISSN":["2052-3211"],"issn-type":[{"type":"electronic","value":"2052-3211"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"article-number":"51"}}